Prognostic properties of the baseline prostate-specific antigen value-insights from the European randomized study of screening for prostate cancer

被引：0
|
作者：
Scherer, Thomas Paul [1 ]
Poyet, Cedric [1 ,2 ]
机构：
[1] Univ Zurich, Univ Hosp Zurich, Dept Urol, Zurich, Switzerland
[2] Univ Hosp Zurich, Dept Urol, Ramistr 100, CH-8091 Zurich, Switzerland
来源：
TRANSLATIONAL ANDROLOGY AND UROLOGY | 2024年 / 13卷 / 03期
关键词：
Screening; prostate-specific antigen (PSA); prostate cancer (PCa); RISK;
D O I：
10.21037/tau-23-606
中图分类号：
R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
摘要：
引用
收藏
页码：473 / 475
页数：3
相关论文
共 50 条
  • [21] Impact of prostate-specific antigen screening on prostate cancer
    Zincke, H
    UROLOGY, 1996, 47 (05) : 783 - 783
  • [22] Updated results from the European Randomized Study of Prostate-Specific Antigen (PSA) Screening for Prostate Cancer: are Asian countries encouraged to promote PSA screening?
    Sugimoto, Mikio
    Kakehi, Yoshiyuki
    ASIAN JOURNAL OF ANDROLOGY, 2012, 14 (04) : 522 - 524
  • [23] Comparative estimation of the prognostic value of the baseline values of serum testosterone and prostate-specific antigen in patients with suspected prostate cancer
    Grigoryev, M. E.
    Ermisheva, O. M.
    ONKOUROLOGIYA, 2012, 8 (01): : 66 - 71
  • [24] Four-year prostate-specific antigen progression in the non-cancer population of the European Randomized Study of Screening for Prostate Cancer
    Páez, A
    Luján, M
    Raaijmakers, R
    Berenguer, A
    BJU INTERNATIONAL, 2003, 92 : 84 - 87
  • [25] Impact of the European Randomized Study of Screening for Prostate Cancer (ERSPC) on prostate-specific antigen (PSA) testing by Dutch general practitioners
    Van der Meer, Saskia
    Kollen, Boudewijn J.
    Hirdes, Willem H.
    Steffens, Martijn G.
    Hoekstra-Weebers, Josette E. H. M.
    Nijman, Rien M.
    Blanker, Marco H.
    BJU INTERNATIONAL, 2013, 112 (01) : 26 - 31
  • [26] Long-term prostate-specific antigen contamination in the Spanish arm of the European Randomized Study of Screening for Prostate Cancer (ERSPC)
    Lujan, M.
    Paez, A.
    Angulo, J. C.
    Granados, R.
    Nevado, M.
    Torres, G. M.
    Berenguer, A.
    ACTAS UROLOGICAS ESPANOLAS, 2016, 40 (03): : 164 - 172
  • [27] Impact of Recent Screening on Predicting the Outcome of Prostate Cancer Biopsy in Men With Elevated Prostate-Specific Antigen Data From the European Randomized Study of Prostate Cancer Screening in Gothenburg, Sweden
    Vickers, Andrew J.
    Cronin, Angel M.
    Aus, Gunnar
    Pihl, Carl-Gustav
    Becker, Charlotte
    Pettersson, Kim
    Scardino, Peter T.
    Hugosson, Jonas
    Lilja, Hans
    CANCER, 2010, 116 (11) : 2612 - 2620
  • [28] Diagnostic accuracy of prostate-specific antigen testing in unscreened men: Results from the European randomized study of prostate cancer screening in Goteborg, Sweden
    Lilja, Hans G.
    Serio, Angel M.
    Vickers, Andrew J.
    Carver, Brett S.
    Hugosson, Jonas
    JOURNAL OF UROLOGY, 2007, 177 (04): : 625 - 625
  • [29] Prostate-specific Antigen-Based Prostate Cancer Screening: Reduction of Prostate Cancer Mortality After Correction for Nonattendance and Contamination in the Rotterdam Section of the European Randomized Study of Screening for Prostate Cancer
    Bokhorst, Leonard P.
    Bangma, Chris H.
    van Leenders, Geert J. L. H.
    Lous, Jan J.
    Moss, Sue M.
    Schroder, Fritz H.
    Roobol, Monique J.
    EUROPEAN UROLOGY, 2014, 65 (02) : 329 - 336
  • [30] Value of Prostate-Specific Antigen and Prostate-Specific Antigen Density in Detection of Prostate Cancer in an Iranian Population of Men
    Ghafoori, Mahyar
    Varedi, Peyman
    Hosseini, Seyed Jalil
    Asgari, Mojgan
    Shakiba, Madjid
    UROLOGY JOURNAL, 2009, 6 (03) : 182 - 188
12345